Parsonage-Turner Syndrome (Neuralgic Amyotrophy): Clinical Overview
Parsonage-Turner syndrome (PTS), or neuralgic amyotrophy, is a rare acute brachial plexopathy featuring severe shoulder pain followed by weakness and atrophy. Immune-mediated mechanism suspected.
Clinical Presentation
- Phase 1 (Acute pain): Sudden, severe, constant shoulder/upper arm pain—often nocturnal, unrelated to position. Lasts days to weeks.
- Phase 2 (Weakness/atrophy): As pain subsides, weakness emerges in specific myotomes (supraspinatus, infraspinatus, deltoid, biceps, serratus anterior most common).
- Sensory changes: Numbness or paresthesia in lateral arm, forearm, thumb (C5–C6 distribution typical).
- Autonomic: Vasomotor changes, hyperhidrosis.
- Bilateral in 10–30%; can affect other plexuses (lumbosacral, phrenic).
Triggers and Associations
- Infections (viral: CMV, EBV, parvovirus, HIV, COVID-19; bacterial)
- Vaccinations (influenza, tetanus, COVID-19—rare)
- Surgery, trauma, strenuous exercise
- Pregnancy, postpartum
- Autoimmune conditions
- Idiopathic (no trigger identified)
Diagnosis
- Clinical: Acute shoulder pain → weakness/atrophy in brachial plexus distribution.
- EMG/NCS: Confirms axonal loss, localizes to plexus (not root/nerve), excludes mimics (cervical radiculopathy, rotator cuff tear, Pancoast tumor).
- MRI brachial plexus: T2 hyperintensity, enhancement (acute); fatty infiltration (chronic).
- Labs: Inflammatory markers, viral serologies, autoantibodies as indicated.
Treatment
- Pain control: NSAIDs, neuropathic agents (gabapentin, pregabalin, duloxetine), short-course opioids if severe. Corticosteroids (oral/IV) may shorten pain phase if given early (limited evidence).
- Physical therapy: Maintain range of motion, prevent contractures, scapular stabilization, progressive strengthening as reinnervation occurs.
- Occupational therapy: Adaptive strategies, assistive devices.
- Immunomodulation: IVIG, plasma exchange—anecdotal; no RCTs. Consider if severe or progressive.
- Surgical: Nerve transfers, tendon transfers for fixed deficits after 12–18 months.
Prognosis
- Pain resolves in weeks to months.
- Motor recovery: 70–90% achieve functional recovery at 1–3 years.
- Residual weakness, fatigue, pain in 30–50%.
- Recurrence: 5–10%.
Early diagnosis avoids unnecessary shoulder surgery. Neurology or physiatry referral recommended.
Genetic Disorders - Related Articles
- Albinism Genetics: OCA Types, Genes, and Chromosomal Locations
- Angelman Syndrome Carrier Frequency: What We Know
- Non‑Heritable Traits: Acquired Characteristics and Environmental Influences
- Punnett Squares for Autosomal Traits With Sex-Influenced Expression
- Bestiality (Zoophilia): Definition, Ethics, and Legal Status
- Understanding 'Fibro' in Medical Terms: Fibrous Tissues Explained
- Living with Neurofibromatosis Type 1 (NF1): Lifespan & Outlook
